BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 12527908)

  • 1. Leukemia-related transcription factor TEL accelerates differentiation of Friend erythroleukemia cells.
    Waga K; Nakamura Y; Maki K; Arai H; Yamagata T; Sasaki K; Kurokawa M; Hirai H; Mitani K
    Oncogene; 2003 Jan; 22(1):59-68. PubMed ID: 12527908
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Myb dependent pathway maintains Friend murine erythroleukemia cells in an immature and proliferating state.
    Chen J; Kremer CS; Bender TP
    Oncogene; 2002 Mar; 21(12):1859-69. PubMed ID: 11896618
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional analysis of a dominant-negative DeltaETS TEL/ETV6 isoform.
    Sasaki K; Nakamura Y; Maki K; Waga K; Nakamura F; Arai H; Imai Y; Hirai H; Mitani K
    Biochem Biophys Res Commun; 2004 May; 317(4):1128-37. PubMed ID: 15094386
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of overexpression of the Ets family transcription factor TEL on cell growth and differentiation of K562 cells.
    Sakurai T; Yamada T; Kihara-Negishi F; Teramoto S; Sato Y; Izawa T; Oikawa T
    Int J Oncol; 2003 Jun; 22(6):1327-33. PubMed ID: 12739001
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nitric oxide-releasing agents and cGMP analogues inhibit murine erythroleukemia cell differentiation and suppress erythroid-specific gene expression: correlation with decreased DNA binding of NF-E2 and altered c-myb mRNA expression.
    Suhasini M; Boss GR; Pascual FE; Pilz RB
    Cell Growth Differ; 1995 Dec; 6(12):1559-66. PubMed ID: 9019161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TEL/ETV6 accelerates erythroid differentiation and inhibits megakaryocytic maturation in a human leukemia cell line UT-7/GM.
    Takahashi W; Sasaki K; Kvomatsu N; Mitani K
    Cancer Sci; 2005 Jun; 96(6):340-8. PubMed ID: 15958056
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TEL2, an ETS factor expressed in human leukemia, regulates monocytic differentiation of U937 Cells and blocks the inhibitory effect of TEL1 on ras-induced cellular transformation.
    Kawagoe H; Potter M; Ellis J; Grosveld GC
    Cancer Res; 2004 Sep; 64(17):6091-100. PubMed ID: 15342392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spi-1/PU.1 but not Fli-1 inhibits erythroid-specific alternative splicing of 4.1R pre-mRNA in murine erythroleukemia cells.
    Théoleyre O; Deguillien M; Morinière M; Starck J; Moreau-Gachelin F; Morlé F; Baklouti F
    Oncogene; 2004 Jan; 23(4):920-7. PubMed ID: 14647452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Jun inhibits NF-E2 transcriptional activity in association with p18/maf in Friend erythroleukemia cells.
    Francastel C; Augery-Bourget Y; Prenant M; Walters M; Martin DI; Robert-Lézénès J
    Oncogene; 1997 Feb; 14(7):873-7. PubMed ID: 9047395
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deregulated expression of the PU.1 transcription factor blocks murine erythroleukemia cell terminal differentiation.
    Rao G; Rekhtman N; Cheng G; Krasikov T; Skoultchi AI
    Oncogene; 1997 Jan; 14(1):123-31. PubMed ID: 9010239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct association between PU.1 and MeCP2 that recruits mSin3A-HDAC complex for PU.1-mediated transcriptional repression.
    Suzuki M; Yamada T; Kihara-Negishi F; Sakurai T; Oikawa T
    Oncogene; 2003 Nov; 22(54):8688-98. PubMed ID: 14647463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Erythroid potentiating activity of tissue inhibitor of metalloproteinases on the differentiation of erythropoietin-responsive mouse erythroleukemia cell line, ELM-I-1-3, is closely related to its cell growth potentiating activity.
    Murate T; Yamashita K; Ohashi H; Kagami Y; Tsushita K; Kinoshita T; Hotta T; Saito H; Yoshida S; Mori KJ
    Exp Hematol; 1993 Jan; 21(1):169-76. PubMed ID: 8417953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iron-responsive element-binding protein mRNA levels during erythroid differentiation of murine erythroleukemia cells.
    Fuchs O
    Neoplasma; 1995; 42(4):179-85. PubMed ID: 7659183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. TEL/AML1 shows dominant-negative effects over TEL as well as AML1.
    Gunji H; Waga K; Nakamura F; Maki K; Sasaki K; Nakamura Y; Mitani K
    Biochem Biophys Res Commun; 2004 Sep; 322(2):623-30. PubMed ID: 15325275
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of mouse GATA-1 function by the glucocorticoid receptor: possible mechanism of steroid inhibition of erythroleukemia cell differentiation.
    Chang TJ; Scher BM; Waxman S; Scher W
    Mol Endocrinol; 1993 Apr; 7(4):528-42. PubMed ID: 8502237
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regions within the c-Myc protein that are necessary for transformation are also required for inhibition of differentiation of murine erythroleukemia cells.
    Bar-Ner M; Messing LT; Cultraro CM; Birrer MJ; Segal S
    Cell Growth Differ; 1992 Mar; 3(3):183-90. PubMed ID: 1633109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The carbonic anhydrase I locus contains a c-Myb target promoter and modulates differentiation of murine erythroleukemia cells.
    Chen J; Kremer CS; Bender TP
    Oncogene; 2006 May; 25(19):2758-72. PubMed ID: 16407849
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interaction between the homeodomain protein HOXC13 and ETS family transcription factor PU.1 and its implication in the differentiation of murine erythroleukemia cells.
    Yamada T; Shimizu T; Suzuki M; Kihara-Negishi F; Nanashima N; Sakurai T; Fan Y; Akita M; Oikawa T; Tsuchida S
    Exp Cell Res; 2008 Feb; 314(4):847-58. PubMed ID: 18076876
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Ets family transcription factor PU.1 in hematopoietic cell differentiation, proliferation and apoptosis.
    Oikawa T; Yamada T; Kihara-Negishi F; Yamamoto H; Kondoh N; Hitomi Y; Hashimoto Y
    Cell Death Differ; 1999 Jul; 6(7):599-608. PubMed ID: 10453070
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cloning and characterization of the novel chimeric gene TEL/PTPRR in acute myelogenous leukemia with inv(12)(p13q13).
    Nakamura F; Nakamura Y; Maki K; Sato Y; Mitani K
    Cancer Res; 2005 Aug; 65(15):6612-21. PubMed ID: 16061641
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.